Appropriate Endpoint for Stage I NSCLC: Correlations of Long-Term Survival with Disease-Free and Recurrence-Free Survival

被引：0
|
作者：
Tan, Kay See [1 ]
Eguchi, Takashi [2 ]
Adusumilli, Prasad [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
overall survival; surgical outcomes; Clinical endpoints; Long term follow-up;
D O I：
10.1016/j.jtho.2016.11.1997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB027
引用
收藏
页码：S1463 / S1463
页数：1
相关论文
共 50 条
  • [31] Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials
    Yin, Jun
    Salem, Mohamed E.
    Dixon, Jesse G.
    Jin, Zhaohui
    Cohen, Romain
    DeGramont, Aimery
    Van Cutsem, Eric
    Taieb, Julien
    Alberts, Steven R.
    Wolmark, Norman
    Schmoll, Hans-Joachim
    Saltz, Leonard B.
    George, Thomas J.
    Goldberg, Richard R. M.
    Kerr, Rachel
    Lonardi, Sara
    Yoshino, Takayuki
    Yothers, Greg
    Grothey, Axel
    Andre, Thierry
    Shi, Qian
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 60 - 67
  • [32] Biochenmical recurrence-free survival: Does it relate to survival?
    Schulz, RJ
    Kagan, AR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04): : 1261 - 1261
  • [33] LCMC3: Long-Term Disease-Free and Overall Survival and their Association with ctDNA after Neoadjuvant Atezolizumab for NSCLC
    Owen, D. H.
    Chaft, J. E.
    Haura, E. B.
    Toloza, E.
    Waqar, S. N.
    Patterson, G. A.
    Finley, D.
    Blasberg, J.
    Raz, D.
    Salgia, R.
    Lee, J. M.
    Bunn, P.
    Wistuba, I.
    Kwiatowski, D. J.
    Hirsch, F. R.
    Gopalakrishnan, A.
    Batra, A.
    Brandao, E.
    Grindheim, J. M.
    Nicholas, A.
    Johnson, A.
    Schulze, K.
    Shum, E.
    Nagasaka, M.
    Gainor, J.
    McNamee, C. J.
    Johnson, B. E.
    Kris, M. G.
    Rusch, V. W.
    Carbone, D. P.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S119 - S119
  • [34] Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma
    Davis, Joy M.
    Rushton, Tullia
    Nsiah, Felicity
    Stone, Rebecca L.
    Beavis, Anna L.
    Gaillard, Stephanie L.
    Dobi, Alice
    Fader, Amanda N.
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 53
  • [35] Recurrence-free survival versus overall survival as a primary endpoint after resection of colorectal liver metastases
    Fritsch, J.
    Ardelt, M.
    Settmacher, U.
    CHIRURGIE, 2023, 94 (03): : 272 - 273
  • [36] POSTINTERVENTIONAL TUMOR NECROSIS PREDICTS RECURRENCE-FREE LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH HCC
    Kornberg, Arno
    Witt, Ulrike
    Novotny, Alexander
    Habrecht, Olaf
    Krause, Babett
    Buechler, Peter
    Friess, Helmut
    TRANSPLANT INTERNATIONAL, 2011, 24 : 201 - 201
  • [37] Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases
    Kao, Johnny
    Sahagian, Michelle
    Gupta, Vani
    Missios, Symeon
    Sangal, Ashish
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Yolk sac tumor of the vulva: a case report with long-term disease-free survival
    Khunamornpong, S
    Siriaunkgul, S
    Suprasert, P
    Chitapanarux, I
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 238 - 242
  • [39] Long-term recurrence-free survival after hepatic resection for metachronous gastric cancer liver metastases
    Peeters, Bert
    Kerstens, Jeroen
    Specenier, Pol
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (04) : 497 - 499
  • [40] Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer
    Felix K.-H. Chun
    Markus Graefen
    Mario Zacharias
    Alexander Haese
    Thomas Steuber
    Thorsten Schlomm
    Jochen Walz
    Pierre I. Karakiewicz
    Hartwig Huland
    World Journal of Urology, 2006, 24 : 273 - 280
12345